title: Immunotherapy in renal cell cancer: the more the merrier?
authors.affiliation: 1 Pharmacology and Clinical Assessment Division, 2 Biotechnology and Advanced Therapies, Spanish Medicines Agency, Campezo 1 - Edificio 8, 28022 - Madrid, Spain.
authors.forename: Jorge
authors.initials: J
authors.lastname: Camarero
authors.affiliation: 1 Pharmacology and Clinical Assessment Division, 2 Biotechnology and Advanced Therapies, Spanish Medicines Agency, Campezo 1 - Edificio 8, 28022 - Madrid, Spain.
authors.forename: Sol
authors.initials: S
authors.lastname: Ruiz
references.citation: Hum Vaccin Immunother. 2012 Sep;8(9):1354-9
references.pmid: 22863755
references.citation: Tissue Antigens. 2012 Mar;79(3):147-54
references.pmid: 22309256
references.citation: Nat Med. 2012 Aug;18(8):1254-61
references.pmid: 22842478
references.citation: Cancer Immunol Immunother. 2011 Aug;60(8):1161-71
references.pmid: 21626032
references.citation: N Engl J Med. 2007 May 31;356(22):2271-81
references.pmid: 17538086
references.citation: Oncology (Williston Park). 2012 Mar;26(3):290-301
references.pmid: 22545314
references.citation: Lancet. 2008 Aug 9;372(9637):449-56
references.pmid: 18653228
references.citation: Anticancer Res. 2012 Mar;32(3):997-1003
references.pmid: 22399623
references.citation: Nat Rev Cancer. 2012 Mar 15;12 (4):298-306
references.pmid: 22419253